Compare Levi Strauss & Co. (LEVI) vs Moderna, Inc. (MRNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Levi Strauss & Co. vs Moderna, Inc. — how do they compare? Levi Strauss & Co. trades at $23.97 (market cap $9.21B), while Moderna, Inc. trades at $59.38 (market cap $23.60B). The key difference: Moderna, Inc. is far larger — about 2.6× Levi Strauss & Co.'s market cap, and Levi Strauss & Co. pays a 2.68% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| LEVI | MRNA | |
|---|---|---|
Market Cap | $9.21B | $23.60B |
Sector | Consumer Cyclical | Health |
52-Week High | $24.99 | $81.80 |
52-Week Low | $17.92 | $22.36 |
Enterprise Value | $10.52B | $19.70B |
Dividend Yield | 2.68% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Levi Strauss & Co.
Levi Strauss & Co is involved in designing, marketing, and selling products that include jeans, casual and dresses pants, tops, shorts, skirts, jackets, footwear, and related accessories directly or through third parties and licensees for men, women, and children under Levi's, Dockers, Signature by Levi Strauss & Co. and Denizen brands. The company manages its business according to three regional segments: the Americas, which is the key revenue driver
Read more on LEVI →About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →
